"In 2010, the FDA took the rare step of conducting its own study of the 300-milligram strength," wrote Thomas. "In early October, it announced that the drug did not, in fact, perform as well as the brand."
Some say concerns raised by the FDA's decision to look more closely at drug-making processes are overblown and that the science behind generics is sound. "There are approximately 10,000 FDA-approved interchangeable generics in the U.S. The recall by a single manufacturer of one strength of a generic drug should in no way cast doubt on the impeccable reputation of the generic industry or the FDA," Ralph Neas, CEO and president of the Generics Pharmaceutical Association, told CBS News.
"David Read, regulatory counsel for the FDA's office of generic drugs, isn't concerned," said an article in Forbes on the closer scrutiny. "According to Read, in the last five years the FDA has only had to correct itself on the equivalence of three drugs. Two cases involved drugs from Dr. Reddy's Laboratories: an antidepressant and an antifungal medication. The third case involved an anti-seizure drug from Upsher-Smith Laboratories."
EMAIL: email@example.com Twitter: Loisco
- Sentenced but never jailed, robber who went...
- Dirty creek, old purse solve four-decade...
- Utah, Oklahoma same-sex marriage cases on...
- Appeals judges question right to sue in...
- Texas seizes FLDS Church's secluded ranch
- How does the world feel about morals and...
- Dress codes: Where should schools set limits?
- Astronomers spot most Earth-like planet yet
- Obama: Religious intolerance has... 76
- Utah, Oklahoma same-sex marriage cases... 43
- The dangers of financially illiterate... 30
- Bureau of Land Management to pursue... 22
- Report projects health law's subsidies... 21
- 'Obamacare' under attack as... 14
- Sentenced but never jailed, robber who... 14
- Obama: 8 million signed up for health care 14